AMYPAD Post-Doc Merle Hoenig presents at SNMMI confrerence
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting is recognised as the
AMYPAD
AMYPAD announces end of recruitment in the Prognostic and Natural History Study
On 11 May, the members of the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) project
AMYPAD hosts a disclosure biomarker symposium
On 1 April, the Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) project held an online
New partnership between AMYPAD and ADDI powers global open access to Alzheimer’s disease imaging data
A common sign of Alzheimer’s disease are deposits of a protein called beta amyloid. The
Neuronet convenes 8th meeting of its Scientific Coordination Board
On 30 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
Neuronet publishes series of project introduction videos during Brain Awareness Week
The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines
New partnership between AMYPAD and ADDI powers global open access to project’s data
The AMYPAD consortium is pleased to announce its collaboration with the Alzheimer’s Disease Data Initiative
AMYPAD project reports on highlights in 2021
The collaboration within the AMYPAD consortium has been productive and efficient during the fifth year of the
Uncertainty of MR-PET image registration is mainly driven by the quality of PET images
Accurate regional brain quantitative PET measurements, particularly when using partial volume correction, rely on robust
Quantifying longitudinal & regional changes in Aβ can improve the prediction of cognitive functioning
The value of quantitative longitudinal and regional amyloid beta (Aβ) measurements in predicting cognitive decline